Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Weber

Showing results (121-130 of 341) with videos related to

Pageof 35
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 16, 2025
Renal denervation for managing hypertension: Key elements in selecting and referring patientsMichael A Weber, Eric A Secemsky, Anna Krawisz, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 31, 2007
First-step use of fixed-dose combination treatment in stage 2 hypertensive patients: has the time come?Michael A Weber, Luis Ruilope, Thomas D Giles, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2012
Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinoprilMichael A Weber, Jan Basile, Manfred Stapff, et al.
The American Journal of Geriatric Cardiology|March 11, 2008
The geriatric paradoxPeter R Kowey, Nanette K Wenger, Michael A Weber, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2008
Beta-blockers in the treatment of hypertension: new data, new directionsMichael A Weber, George L Bakris, Thomas D Giles, et al.
Lancet (London, England)|August 14, 2022
Data at 36 months for the Symplicity SPYRAL HTN-ON MED pilot - Authors' replyFelix Mahfoud, David E Kandzari, Michael A Weber, et al.
The American Journal of Geriatric Cardiology|May 11, 2004
Treatment of elderly hypertensive patients with a delayed-release verapamil formulation in a community-based trialMichael A Weber, L Michael Prisant, Henry R Black, et al.
American Journal of Hypertension|March 6, 2004
Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazideSteven G Chrysant, Michael A Weber, Antonia C Wang, et al.
American Journal of Therapeutics|December 1, 1995
The Therapeutic Implications of Left Ventricular Hypertrophy in the Hypertensive PatientMichael A. Weber, David H.G. Smith, Joel M. Neutel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2007
A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to moderate hypertensionRobert J Weiss, Michael A Weber, Albert A Carr, et al.
Pageof 35

Showing results (121-130 of 341) with videos related to

Sort By:
Pageof 35
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 16, 2025
Renal denervation for managing hypertension: Key elements in selecting and referring patientsMichael A Weber, Eric A Secemsky, Anna Krawisz, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 31, 2007
First-step use of fixed-dose combination treatment in stage 2 hypertensive patients: has the time come?Michael A Weber, Luis Ruilope, Thomas D Giles, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2012
Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinoprilMichael A Weber, Jan Basile, Manfred Stapff, et al.
The American Journal of Geriatric Cardiology|March 11, 2008
The geriatric paradoxPeter R Kowey, Nanette K Wenger, Michael A Weber, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2008
Beta-blockers in the treatment of hypertension: new data, new directionsMichael A Weber, George L Bakris, Thomas D Giles, et al.
Lancet (London, England)|August 14, 2022
Data at 36 months for the Symplicity SPYRAL HTN-ON MED pilot - Authors' replyFelix Mahfoud, David E Kandzari, Michael A Weber, et al.
The American Journal of Geriatric Cardiology|May 11, 2004
Treatment of elderly hypertensive patients with a delayed-release verapamil formulation in a community-based trialMichael A Weber, L Michael Prisant, Henry R Black, et al.
American Journal of Hypertension|March 6, 2004
Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazideSteven G Chrysant, Michael A Weber, Antonia C Wang, et al.
American Journal of Therapeutics|December 1, 1995
The Therapeutic Implications of Left Ventricular Hypertrophy in the Hypertensive PatientMichael A. Weber, David H.G. Smith, Joel M. Neutel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2007
A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to moderate hypertensionRobert J Weiss, Michael A Weber, Albert A Carr, et al.
Pageof 35